Detail akcie Virbac SA online

Business Summary: Virbac SA is a France-based veterinarian pharmaceutical company that specializes in the development and production of vaccines and medicines for domestic animals and livestock. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus mainly on formulating drugs designed to prevent or cure certain animal diseases. Its product portfolio encompasses pet medications such as pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds and rodents, as well as livestock medications including pest control drugs and antibiotics intended for cattle, sheep, pigs and poultry. It also offers food and electronic identification chips for pets.
Financial Summary: BRIEF: For the six months ended 30 June 2023, Virbac SA revenues decreased 1% to EUR610.5M. Net income applicable to common stockholders decreased 3% to EUR75M. Revenues reflect Food Producing Animals segment decrease of 3% to EUR240.9M, Companion Animals segment decrease of 1% to EUR350M, Asia segment decrease of 7% to EUR99.2M, Latin America segment decrease of 3% to EUR98.3M.